<p>，/PRNewswire/ -- Genesis Innovation Group (GIG) 是一家總部位於美國的醫療設備開發公司，負責將概念從構思轉化為商業化，宣佈成立其最新子公司 Capitan Orthopedics, Inc.</p>
<p>Capitan Orthopedics 的 SupraSpacerTM 微創植入物提供了一種長期的生物力學解決方案，解決不可修復的肩袖撕裂問題。SupraSpacerTM 植入物恢復關節對齊，並允許無痛的活動範圍，同時保留未來的手術選擇。</p>
<p>“如今，每年有超過 200 萬人被診斷為肩袖損傷，超過 700,000 人接受手術修復主要的肩袖撕裂。但是，目前護理連續體中存在巨大的空白，長期以來，患有不可修復肩袖撕裂的患者面臨有限的手術選擇和沒有長期解決方案的困境。我們的專家設計外科醫生和工程師團隊創造了一種新型植入物和簡單、可重複的手術程序，為外科醫生提供了一種急需的手術選擇，積極影響患者護理，” Genesis Innovation Group 和 Capitan Orthopedics, Inc. 的首席執行官 Chance Leonard 説道。</p>
<p>首席外科設計師 R. Sean Churchill 醫生表示：“與 Capitan Orthopedics 合作令人興奮，因為該公司承擔了應對當今骨科外科醫生面臨的最常見和最令人沮喪的肩部疾病之一的挑戰——在 25 至 60 歲患者中出現的疼痛性不可修復肩袖撕裂。幾代人以來，外科醫生嘗試了從物理治療、注射、肌腱轉移到關節囊重建的各種方法。不幸的是，這些治療往往失敗，使患者感到沮喪，肩部疼痛、虛弱且功能不良。SupraSpacerTM 專為這些患者設計。通過幫助保持肱骨頭在關節中的中心，植入物不僅降低了肩關節炎的風險和進展，還消除了肱骨頭在肩峯下表面的疼痛接觸，從而允許完全無夾擊的活動範圍。”</p>
<p>Leonard 先生補充道：“不可修復的肩袖撕裂影響着相當數量的患者羣體，我們相信一種簡單但持久、可重複的微創、節省骨骼的手術程序既是外科醫生會接受的解決方案，也是患者會感激的解決方案。我們迫切希望儘快將 SupraSpacerTM 推向市場。”</p>
<p><strong>關於 Genesis Innovation Group</strong></p>
<p>Genesis Innovation Group 是醫療設備開發和商業化的領導者。該公司與發明家、企業家和早期階段的醫療設備公司合作，開發創新技術，積極影響患者護理並提供更好的患者結果。Genesis 團隊擁有 377 年的工程經驗，獲得了 227 項專利，生成了 154 項 510k 清關，並幫助實現了 13 次成功退出。</p>
<p>瞭解更多關於 Genesis Innovation Group 和 Capitan Orthopedics, Inc. 的信息，請訪問： https://genesisinnovationgroup.com 和 capitanortho.com。</p>
<p>Jill Wachter</p>
<p>https://genesisinnovationgroup.com</p>
<p>來源：Genesis Innovation Group</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIwJk5ld3NJdGVtSWQ9Rkw2NTQ2NSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjAwNTI1UFJfTkVXU19VU1BSX19fX19GTDY1NDY1?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIwJk5ld3NJdGVtSWQ9Rkw2NTQ2NSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjAwNTI1UFJfTkVXU19VU1BSX19fX19GTDY1NDY1"/></p>

<p>Genesis Innovation Group (GIG) 宣佈成立其新子公司 Capitan Orthopedics, Inc.，該公司將專注於為患有不可修復的肩袖撕裂的患者設計 SupraSpacerTM 植入物。這種微創植入物旨在恢復關節對齊，併為每年超過 200 萬例肩袖損傷診斷提供長期解決方案。首席執行官 Chance Leonard 強調了為遭受這種病症的患者提供更好外科選擇的必要性，而首席外科設計師 R. Sean Churchill 則強調了該植入物改善患者結果和降低肩關節炎風險的潛力</p>

<p>, /PRNewswire/ -- Genesis Innovation Group (GIG), a U.S.-based medical device development firm that takes concepts from ideation to commercialization, announces the formation of its newest subsidiary, Capitan Orthopedics, Inc.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Genesis Innovation Group (GIG) 是一家總部位於美國的醫療設備開發公司，負責將概念從構思轉化為商業化，宣佈成立其最新子公司 Capitan Orthopedics, Inc.</p>
</div><p>Capitan Orthopedics' SupraSpacerTM minimally invasive implant provides a long-term, biomechanical solution that addresses irreparable rotator cuff tears. The SupraSpacerTM implant restores joint alignment and allows for pain free range of motion, while also preserving future surgical options.</p>
<div class="lb-trans"><p>Capitan Orthopedics 的 SupraSpacerTM 微創植入物提供了一種長期的生物力學解決方案，解決不可修復的肩袖撕裂問題。SupraSpacerTM 植入物恢復關節對齊，並允許無痛的活動範圍，同時保留未來的手術選擇。</p>
</div><p>&#34;Today, over 2 million people a year are diagnosed with a rotator cuff injury and over 700,000+ undergo surgery to repair a primary rotator cuff tear. But, there is a massive gap in the current care continuum and for far too long patients with irreparable cuff tears have suffered with limited surgical options and no long-term solution. Our team of expert design surgeons and engineers have created a novel implant and a simple, reproducible procedure that provides surgeons with a desperately needed surgical option that positively impacts patient care,&#34; said Chance Leonard, CEO of Genesis Innovation Group and Capitan Orthopedics, Inc.</p>
<div class="lb-trans"><p>“如今，每年有超過 200 萬人被診斷為肩袖損傷，超過 700,000 人接受手術修復主要的肩袖撕裂。但是，目前護理連續體中存在巨大的空白，長期以來，患有不可修復肩袖撕裂的患者面臨有限的手術選擇和沒有長期解決方案的困境。我們的專家設計外科醫生和工程師團隊創造了一種新型植入物和簡單、可重複的手術程序，為外科醫生提供了一種急需的手術選擇，積極影響患者護理，” Genesis Innovation Group 和 Capitan Orthopedics, Inc. 的首席執行官 Chance Leonard 説道。</p>
</div><p>R. Sean Churchill, MD, MBA, lead surgeon designer said, &#34;It's exciting to work with Capitan Orthopedics as the company has taken on the challenge of addressing one of the most common and frustrating shoulder conditions facing orthopedic surgeons today - the painful, irreparable, rotator cuff tear in patients aged 25-60. For generations, surgeons have tried everything from physical therapy, injections, tendon transfers and capsular reconstructions. Unfortunately, and all too often, these treatments fail and leave the patients frustrated with painful, weak, and poorly functioning shoulders. The SupraSpacerTM is specifically designed for these patients. By helping maintain the humeral head centered in the joint, the implant not only reduces the risk and advancement of shoulder arthritis, but removes the painful abutment of the humeral head on the undersurface of the acromion, allowing for full impingement free range of motion.&#34;</p>
<div class="lb-trans"><p>首席外科設計師 R. Sean Churchill 醫生表示：“與 Capitan Orthopedics 合作令人興奮，因為該公司承擔了應對當今骨科外科醫生面臨的最常見和最令人沮喪的肩部疾病之一的挑戰——在 25 至 60 歲患者中出現的疼痛性不可修復肩袖撕裂。幾代人以來，外科醫生嘗試了從物理治療、注射、肌腱轉移到關節囊重建的各種方法。不幸的是，這些治療往往失敗，使患者感到沮喪，肩部疼痛、虛弱且功能不良。SupraSpacerTM 專為這些患者設計。通過幫助保持肱骨頭在關節中的中心，植入物不僅降低了肩關節炎的風險和進展，還消除了肱骨頭在肩峯下表面的疼痛接觸，從而允許完全無夾擊的活動範圍。”</p>
</div><p>Mr. Leonard added, &#34;Irreparable rotator cuff tears affect a sizable patient population and we believe that a simple, but lasting, repeatable, minimally-invasive, bone-sparing procedure is both a solution surgeons will embrace, and one that patients will appreciate. We are eager to bring SupraSpacerTM to the market as soon as possible.&#34;</p>
<div class="lb-trans"><p>Leonard 先生補充道：“不可修復的肩袖撕裂影響着相當數量的患者羣體，我們相信一種簡單但持久、可重複的微創、節省骨骼的手術程序既是外科醫生會接受的解決方案，也是患者會感激的解決方案。我們迫切希望儘快將 SupraSpacerTM 推向市場。”</p>
</div><p><strong>About Genesis Innovation Group</strong></p>
<div class="lb-trans"><p><strong>關於 Genesis Innovation Group</strong></p>
</div><p>Genesis Innovation Group is the leader in medical device development and commercialization. The company partners with inventors, entrepreneurs, and early stage medical device companies to develop innovative technologies that positively impact patient care and deliver better patient outcomes. The Genesis team has a combined 377 years of engineering experience, has amassed 227 patents, has generated 154 510k clearances and has helped deliver 13 successful exits.</p>
<div class="lb-trans"><p>Genesis Innovation Group 是醫療設備開發和商業化的領導者。該公司與發明家、企業家和早期階段的醫療設備公司合作，開發創新技術，積極影響患者護理並提供更好的患者結果。Genesis 團隊擁有 377 年的工程經驗，獲得了 227 項專利，生成了 154 項 510k 清關，並幫助實現了 13 次成功退出。</p>
</div><p>Learn more about Genesis Innovation Group and Capitan Orthopedics, Inc. at: https://genesisinnovationgroup.com and capitanortho.com.</p>
<div class="lb-trans"><p>瞭解更多關於 Genesis Innovation Group 和 Capitan Orthopedics, Inc. 的信息，請訪問： https://genesisinnovationgroup.com 和 capitanortho.com。</p>
</div><p>Jill Wachter</p>
<div class="lb-trans"><p>Jill Wachter</p>
</div><p>https://genesisinnovationgroup.com</p>
<div class="lb-trans"><p>https://genesisinnovationgroup.com</p>
</div><p>SOURCE Genesis Innovation Group</p>
<div class="lb-trans"><p>來源：Genesis Innovation Group</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIwJk5ld3NJdGVtSWQ9Rkw2NTQ2NSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjAwNTI1UFJfTkVXU19VU1BSX19fX19GTDY1NDY1" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=FL65465&amp;Transmission_Id=202601200525PR_NEWS_USPR_____FL65465&amp;DateId=20260120"/></p>

創世紀創新集團宣佈成立新子公司 Capitan Orthopedics, Inc